Intl. Biotechnology Trust PLC Result of AGM
09 Dicembre 2024 - 6:38PM
RNS Regulatory News
RNS Number : 4040P
Intl. Biotechnology Trust PLC
09 December 2024
Annual General
Meeting
International Biotechnology Trust plc
(the "Company") announces that a poll was held on each of the
resolutions proposed at the Annual General Meeting ("AGM") on 9
December 2024. The results of the poll are:
|
|
Resolution
|
Votes For
|
%
|
Votes
Against
|
%
|
Votes
Withheld
|
Total Votes Cast (excl. Votes
Withheld)
|
% of Issued Share
Capital
|
|
1
|
To receive the Annual Report and
Financial Statements
|
8,760,743
|
87.49%
|
1,252,909
|
12.51%
|
6,308
|
10,013,652
|
27.60
|
|
2
|
To approve the Company's dividend
policy
|
10,003,330
|
99.92%
|
8,084
|
0.08%
|
8,546
|
10,011,414
|
27.60
|
|
3
|
To approve the Directors'
Remuneration Report
|
9,931,300
|
99.40%
|
59,483
|
0.60%
|
29,177
|
9,990,783
|
27.54
|
|
4
|
To approve the Directors'
Remuneration Policy
|
9,930,997
|
99.39%
|
60,885
|
0.61%
|
28,078
|
9,991,882
|
27.54
|
|
5
|
To re-elect Gillian
Elcock
|
9,963,843
|
99.65%
|
35,099
|
0.35%
|
21,018
|
9,998,942
|
27.56
|
|
6
|
To re-elect Kate
Cornish-Bowden
|
9,966,713
|
99.68%
|
32,229
|
0.32%
|
21,018
|
9,998,942
|
27.56
|
|
7
|
To re-elect Caroline
Gulliver
|
8,716,760
|
87.18%
|
1,282,182
|
12.82%
|
21,018
|
9,998,942
|
27.56
|
|
8
|
To re-elect Patrick
Magee
|
9,967,138
|
99.77%
|
23,135
|
0.23%
|
29,687
|
9,990,273
|
27.54
|
|
9
|
To re-elect Patrick
Maxwell
|
9,976,368
|
99.75%
|
25,405
|
0.25%
|
18,187
|
10,001,773
|
27.57
|
|
10
|
To re-appoint PricewaterhouseCoopers
LLP as auditors
|
8,710,798
|
87.10%
|
1,290,119
|
12.90%
|
19,043
|
10,000,917
|
27.57
|
|
11
|
To authorise Directors'
determination of the auditors' remuneration
|
9,982,978
|
99.79%
|
21,084
|
0.21%
|
15,898
|
10,004,062
|
27.58
|
|
12
|
To renew the Directors' authority to
allot shares
|
9,980,515
|
99.70%
|
30,129
|
0.30%
|
9,316
|
10,010,644
|
27.59
|
|
13*
|
To approve the disapplication of
pre-emption rights
|
9,929,824
|
99.25%
|
75,015
|
0.75%
|
15,121
|
10,004,839
|
27.58
|
|
14*
|
To renew the authority to make
market purchases of the Company's own shares
|
9,412,881
|
94.02%
|
598,193
|
5.98%
|
8,886
|
10,011,074
|
27.60
|
|
15*
|
To approve the adoption of the new
Articles of Association
|
9,979,295
|
99.77%
|
23,469
|
0.23%
|
17,196
|
10,002,764
|
27.57
|
|
16*
|
To approve that a general meeting,
other than an annual general meeting, may be called on not less
than 14 clear days' notice
|
9,947,439
|
99.40%
|
60,413
|
0.60%
|
12,108
|
10,007,852
|
27.59
|
*Resolution 13 to 16 were passed as
special resolutions.
Shareholders are entitled to one
vote per share. Votes withheld are not a vote in law and are
therefore not counted in the calculation of the percentages of the
votes cast for and against a resolution. Where shareholders
appointed the Chair as their proxy with discretion as to voting,
their votes were cast in favour of the resolutions and their shares
have been included in the "votes for" column.
The total issued share capital
consists of 41,383,817 ordinary shares of £0.25 each,
which includes 5,105,511 ordinary shares held in treasury. Treasury
shares do not carry voting rights, therefore the total number
voting rights in the Company is 36,278,306.
In accordance with UKLR
6.4.2, a copy of the resolutions
passed, other than the resolutions concerning ordinary business, at
today's AGM will be submitted to the National Storage Mechanism and
will be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The proxy votes lodged with the
Company's Registrar will shortly be available via the Company's
webpages at
International Biotechnology Trust plc -
IBT.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RAGFSIFWUELSEDE
Grafico Azioni International Biotechnol... (LSE:IBT)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni International Biotechnol... (LSE:IBT)
Storico
Da Dic 2023 a Dic 2024
